100 related articles for article (PubMed ID: 30655214)
1. Binding inhibition of various influenza viruses by sialyllactose-modified trimer DNAs.
Yamabe M; Kaihatsu K; Ebara Y
Bioorg Med Chem Lett; 2019 Mar; 29(5):744-748. PubMed ID: 30655214
[TBL] [Abstract][Full Text] [Related]
2. Sialyllactose-Modified Three-Way Junction DNA as Binding Inhibitor of Influenza Virus Hemagglutinin.
Yamabe M; Kaihatsu K; Ebara Y
Bioconjug Chem; 2018 May; 29(5):1490-1494. PubMed ID: 29566328
[TBL] [Abstract][Full Text] [Related]
3. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine).
Gambaryan AS; Tuzikov AB; Piskarev VE; Yamnikova SS; Lvov DK; Robertson JS; Bovin NV; Matrosovich MN
Virology; 1997 Jun; 232(2):345-50. PubMed ID: 9191848
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-functionalized chitosan fiber for influenza virus capture.
Li X; Wu P; Gao GF; Cheng S
Biomacromolecules; 2011 Nov; 12(11):3962-9. PubMed ID: 21978096
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation.
Peng W; Bouwman KM; McBride R; Grant OC; Woods RJ; Verheije MH; Paulson JC; de Vries RP
J Virol; 2018 May; 92(10):. PubMed ID: 29491160
[TBL] [Abstract][Full Text] [Related]
6. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid.
Wu W; Air GM
Virology; 2004 Aug; 325(2):340-50. PubMed ID: 15246273
[TBL] [Abstract][Full Text] [Related]
7. Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus.
Tsuchida A; Kobayashi K; Matsubara N; Muramatsu T; Suzuki T; Suzuki Y
Glycoconj J; 1998 Nov; 15(11):1047-54. PubMed ID: 10386889
[TBL] [Abstract][Full Text] [Related]
8. Antiviral potential of 3'-sialyllactose- and 6'-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses.
Günther SC; Maier JD; Vetter J; Podvalnyy N; Khanzhin N; Hennet T; Stertz S
Sci Rep; 2020 Jan; 10(1):768. PubMed ID: 31964943
[TBL] [Abstract][Full Text] [Related]
9. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.
Sauter NK; Hanson JE; Glick GD; Brown JH; Crowther RL; Park SJ; Skehel JJ; Wiley DC
Biochemistry; 1992 Oct; 31(40):9609-21. PubMed ID: 1327122
[TBL] [Abstract][Full Text] [Related]
10. Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
Nie C; Parshad B; Bhatia S; Cheng C; Stadtmüller M; Oehrl A; Kerkhoff Y; Wolff T; Haag R
Angew Chem Int Ed Engl; 2020 Sep; 59(36):15532-15536. PubMed ID: 32421225
[TBL] [Abstract][Full Text] [Related]
11. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of neuraminidase-resistant sialoside-modified three-way junction DNA and its binding ability to various influenza viruses.
Yamabe M; Fujita A; Kaihatsu K; Ebara Y
Carbohydr Res; 2019 Feb; 474():43-50. PubMed ID: 30711767
[TBL] [Abstract][Full Text] [Related]
13. Monovalent sialosides that bind tightly to influenza A virus.
Toogood PL; Galliker PK; Glick GD; Knowles JR
J Med Chem; 1991 Oct; 34(10):3138-40. PubMed ID: 1920363
[No Abstract] [Full Text] [Related]
14. 6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
Sriwilaijaroen N; Suzuki K; Takashita E; Hiramatsu H; Kanie O; Suzuki Y
J Antimicrob Chemother; 2015 Oct; 70(10):2797-809. PubMed ID: 26169554
[TBL] [Abstract][Full Text] [Related]
15. Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses.
Gulati U; Wu W; Gulati S; Kumari K; Waner JL; Air GM
Virology; 2005 Aug; 339(1):12-20. PubMed ID: 15950996
[TBL] [Abstract][Full Text] [Related]
16. Mucin-Inspired, High Molecular Weight Virus Binding Inhibitors Show Biphasic Binding Behavior to Influenza A Viruses.
Wallert M; Nie C; Anilkumar P; Abbina S; Bhatia S; Ludwig K; Kizhakkedathu JN; Haag R; Block S
Small; 2020 Nov; 16(47):e2004635. PubMed ID: 33135314
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus.
Zevgiti S; Zabala JG; Darji A; Dietrich U; Panou-Pomonis E; Sakarellos-Daitsiotis M
J Pept Sci; 2012 Jan; 18(1):52-8. PubMed ID: 22052803
[TBL] [Abstract][Full Text] [Related]
18. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
19. Direct and label-free influenza virus detection based on multisite binding to sialic acid receptors.
Horiguchi Y; Goda T; Matsumoto A; Takeuchi H; Yamaoka S; Miyahara Y
Biosens Bioelectron; 2017 Jun; 92():234-240. PubMed ID: 28222368
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
Andersen O; Vilsgaard Ravn K; Juul Sørensen I; Jonson G; Holm Nielsen E; Svehag SE
Scand J Immunol; 1997 Oct; 46(4):331-7. PubMed ID: 9350282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
